Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fangfang Liu

Showing results (491-500 of 535) with videos related to

Pageof 54
Sort By:
Scientific Reports|May 24, 2016
Human papillomavirus DNA positivity and seropositivity in rural Chinese men and women: a population-based cross-sectional studyFangfang Liu, Qiuju Deng, Chanyuan Zhang, et al.
Cell Reports. Medicine|March 20, 2026
HE4 drives PD-L1 expression in myeloid cells via IFN-γR-JAK-STAT3 signaling to promote tumor immune evasionBo Zeng, Yingying Zhou, Heping Wang, et al.
Molecular Cancer Therapeutics|April 27, 2018
Targeting AKT with Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma <i>In Vitro</i> and Patient-Derived Xenografts <i>In Vivo</i>Mengqiu Song, Xuejiao Liu, Kangdong Liu, et al.
Gastrointestinal Endoscopy|January 9, 2020
A clinical model predicting the risk of esophageal high-grade lesions in opportunistic screening: a multicenter real-world study in ChinaZhen Liu, Chuanhai Guo, Yujie He, et al.
Annals of Surgical Oncology|February 19, 2022
Combined Mean Corpuscular Hemoglobin, Fibrinogen, and Albumin (MF-A) Is a Novel Prognostic Marker in Patients with Resectable Esophageal Squamous Cell CarcinomaLinlin Liang, Fangfang Liu, Wenlei Yang, et al.
BMC Medicine|May 22, 2026
γH2AX and p53 Immunohistochemistry predict the incidence risk of esophageal squamous precancerous lesionsXiangwen Cheng, Ying Liu, Huanyu Chen, et al.
Pharmacoeconomics|February 28, 2019
Estimation of Cost for Endoscopic Screening for Esophageal Cancer in a High-Risk Population in Rural China: Results from a Population-Level Randomized Controlled TrialFuxiao Li, Xiang Li, Chuanhai Guo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 14, 2019
Absence of Iodine Staining Associates With Progression of Esophageal Lesions in a Prospective Endoscopic Surveillance Study in ChinaMengfei Liu, Zhen Liu, Fangfang Liu, et al.
Clinical and Translational Gastroenterology|March 3, 2025
An Image-Based Model for Assisting in Diagnosing Malignant Esophageal Lesions During Lugol Chromoendoscopic ExaminationMengfei Liu, Zifan Qi, Ren Zhou, et al.
BMC Medicine|July 6, 2026
Effect of endoscopic screening for non-cardia gastric cancer: a 12-year report of a population-based randomized trialMengfei Liu, Wenlei Yang, Chuanhai Guo, et al.
Pageof 54

Showing results (491-500 of 535) with videos related to

Sort By:
Pageof 54
Scientific Reports|May 24, 2016
Human papillomavirus DNA positivity and seropositivity in rural Chinese men and women: a population-based cross-sectional studyFangfang Liu, Qiuju Deng, Chanyuan Zhang, et al.
Cell Reports. Medicine|March 20, 2026
HE4 drives PD-L1 expression in myeloid cells via IFN-γR-JAK-STAT3 signaling to promote tumor immune evasionBo Zeng, Yingying Zhou, Heping Wang, et al.
Molecular Cancer Therapeutics|April 27, 2018
Targeting AKT with Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma <i>In Vitro</i> and Patient-Derived Xenografts <i>In Vivo</i>Mengqiu Song, Xuejiao Liu, Kangdong Liu, et al.
Gastrointestinal Endoscopy|January 9, 2020
A clinical model predicting the risk of esophageal high-grade lesions in opportunistic screening: a multicenter real-world study in ChinaZhen Liu, Chuanhai Guo, Yujie He, et al.
Annals of Surgical Oncology|February 19, 2022
Combined Mean Corpuscular Hemoglobin, Fibrinogen, and Albumin (MF-A) Is a Novel Prognostic Marker in Patients with Resectable Esophageal Squamous Cell CarcinomaLinlin Liang, Fangfang Liu, Wenlei Yang, et al.
BMC Medicine|May 22, 2026
γH2AX and p53 Immunohistochemistry predict the incidence risk of esophageal squamous precancerous lesionsXiangwen Cheng, Ying Liu, Huanyu Chen, et al.
Pharmacoeconomics|February 28, 2019
Estimation of Cost for Endoscopic Screening for Esophageal Cancer in a High-Risk Population in Rural China: Results from a Population-Level Randomized Controlled TrialFuxiao Li, Xiang Li, Chuanhai Guo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 14, 2019
Absence of Iodine Staining Associates With Progression of Esophageal Lesions in a Prospective Endoscopic Surveillance Study in ChinaMengfei Liu, Zhen Liu, Fangfang Liu, et al.
Clinical and Translational Gastroenterology|March 3, 2025
An Image-Based Model for Assisting in Diagnosing Malignant Esophageal Lesions During Lugol Chromoendoscopic ExaminationMengfei Liu, Zifan Qi, Ren Zhou, et al.
BMC Medicine|July 6, 2026
Effect of endoscopic screening for non-cardia gastric cancer: a 12-year report of a population-based randomized trialMengfei Liu, Wenlei Yang, Chuanhai Guo, et al.
Pageof 54